Webinar: Reduce Risk, Cost and Time in the New Era of Small Molecule Drug Discovery
Register Here
With the renaissance of Small Molecule Drug Discovery, the race to explore uncharted biologically active chemical space is on. However, the process of discovery has multiple challenges that have an impact on time, cost and risk to any Biotech working towards a therapeutic breakthrough.
Join us for our webinar on 18 August at 4pm BST/11am EDT, where we will highlight the challenges and show how to remove these avoidable risks, costs and time to accelerate your path to discovery.
Speaker: Haydn Boehm
Haydn is the Director of Product Marketing for Dotmatics focussed on helping the life science and drug discovery industries learn how Dotmatics’ R&D software solutions can harmonize their science and data, and accelerate innovation to make the world a healthier, cleaner, better place to live. on the . Haydn has 20 years sales and marketing leadership experience in the life science industry working with companies such as ThermoFisher Scientific, Johnson Matthey and more recently with Merck KGaA’s Connected Lab Program. Haydn has a PhD in Organic Chemistry from the University of Nottingham, UK., and lives on the Jurassic Coast in Devon, UK with his family.
